Novo Nordisk Competitors and Similar CompaniesClear all

Novo Nordisk's competitors and similar companies include Mankind Pharma, Abbott and Gilead Sciences.

	Novo Nordisk Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Abbott Abbott Laboratories is a company that provides healthcare technologies.	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Founding Date	Founding Date 1923	Founding Date 1995	Founding Date 1894	Founding Date 1987
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare diabetes drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare drug development medical devices medical diagnostics nutrition pharma women's health	Tags Manufacturing & Industrial biotech clinical research drug development pharma
Locations	Locations Bagsværd, DK HQ Tirana, AL Boufarik, DZ Hydra, DZ Tizi Ouzou, DZ Buenos Aires, AR North Sydney, AU see more	Locations New Delhi, IN HQ	Locations Abbott Park, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU East Brisbane, AU Macquarie Park, AU see more	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more
Employees	Employees 69,260	Employees 14,2112% increase	Employees 114,0001% decrease	Employees 18,0006% increase
Valuation ($)	Valuation ($) 599.3 b	Valuation ($) N/A	Valuation ($) 196.1 b	Valuation ($) 105.3 b
Financial
Revenue (est.)	Revenue (est.) kr232.3b (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $40.1b (FY, 2023)	Revenue (est.) $27.1b (FY, 2023)
Cost of goods	Cost of goods kr30.8b (FY, 2023)	Cost of goods N/A	Cost of goods $18b (FY, 2023)	Cost of goods $6.5b (FY, 2023)
Gross profit	Gross profit kr202b (FY, 2023)	Gross profit N/A	Gross profit $22.1b (FY, 2023)	Gross profit $20.6b (FY, 2023)
Net income	Net income kr83.7b (FY, 2023)	Net income N/A	Net income $5.7b (FY, 2023)	Net income $5.6b (FY, 2023)